Multiple concurrent collagenase clostridium histolyticum injections to dupuytrens cords: An exploratory study

BMC Musculoskeletal Disorders

Volumn 13, Issue , 2012, Pages

  Coleman, Stephen ^a   Gilpin, David ^a   Tursi, James ^b   Kaufman, Greg ^b   Jones, Nigel ^c   Cohen, Brian ^b  

^a Brisbane Hand and Upper Limb Clinic   (Australia)

^b Auxilium Pharmaceuticals Inc   (United States)

^c Auxilium Pharmaceuticals Inc   (United Kingdom)

Author keywords

collagenase clostridium histolyticum (CCH); contracture; Dupuytrens disease; metacarpophalangeal joint; multiple injections; nonsurgical treatment; palpable cord; proximal interphalangeal joint

Indexed keywords

CLOSTRIDIOPEPTIDASE A;

ADULT; AGED; ARTICLE; BLISTER; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTUSION; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DUPUYTREN CONTRACTURE; FEMALE; FINGER; HAND; HUMAN; INJECTION SITE PAIN; JOINT CONTRACTURE; LACERATION; LYMPHADENOPATHY; MALE; METACARPOPHALANGEAL JOINT; MULTIPLE CYCLE TREATMENT; OPEN STUDY; PAIN; PARESTHESIA; PERIPHERAL EDEMA; PILOT STUDY; PROXIMAL INTERPHALANGEAL JOINT; PRURITUS; SINGLE DRUG DOSE; SKIN DISCOLORATION;

AGE OF ONSET; DRUG ADMINISTRATION SCHEDULE; DUPUYTREN CONTRACTURE; FEMALE; HUMANS; INJECTIONS, INTRALESIONAL; MALE; MICROBIAL COLLAGENASE; MIDDLE AGED; PILOT PROJECTS; QUEENSLAND; TIME FACTORS; TREATMENT OUTCOME;

EID: 84862160062     PISSN: None     EISSN: 14712474     Source Type: Journal    
DOI: 10.1186/1471-2474-13-61     Document Type: Article

References (19)

1. Dupuytrens disease: anatomy, pathology, presentation, and treatment. Rayan GM, J Bone Joint Surg Am 2007 89 189 198 10.1302/0301-620X.89B2.18161 17256226 (Pubitemid 46421464)
2. Dupuytrens contracture; a new concept of the pathogenesis correlated with surgical management. Luck JV, J Bone Joint Surg Am 1959 41-A 4 635 664 13664703
3. Dupuytrens diseasea study of the pattern of distribution and stage of contracture in the hand. Mikkelsen OA, Hand 1976 8 3 265 271 10.1016/0072-968X(76)90013-9 976827
4. Dupuytrens contracture: an audit of the outcomes of surgery. Dias JJ, Braybrooke J, J Hand Surg Br 2006 31 5 514 521 10.1016/j.jhsb.2006.05.005 16837113 (Pubitemid 44321360)
5. Dupuytrens diathesis revisited: evaluation of prognostic indicators for risk of disease recurrence. Hindocha S, Stanley JK, Watson S, Bayat A, J Hand Surg Am 2006 31 10 1626 1634 10.1016/j.jhsa.2006.09.006 17145383 (Pubitemid 44834570)
6. Greens Operative Hand Surgery. McGrouther DA, Dupuytrens contracture Elsevier Churchill Livingstone, Philadelphia, PA, Green DP, Hotchkiss RN, Pederson WC, Wolfe SW, 5 2005 159 185 22836141
7. Dupuytrens disease: history, diagnosis, and treatment. Shaw RB, Chong AK, Zhang A, Hentz VR, Chang J, Plast Reconstr Surg 2007 120 3 44e 54e 10.1097/01.prs.0000278455.63546.03 17700106 (Pubitemid 47258297)
8. Molecular mechanisms and treatment strategies for Dupuytrens disease. OGorman DB, Vi L, Gan BS, Ther Clin Risk Manage 2010 6 383 390
9. The outcome of surgical treatments for primary Dupuytrens diseasea systematic review. Becker GW, Davis TRC, J Hand Surg Br 2010 35 8 623 626
10. Surgical complications associated with fasciectomy for Dupuytrens disease: a 20-year review of the English literature. Denkler K, Eplasty 2010 10 15 20204055
11. Collagenase clostridium histolyticum for Dupuytrens contracture. Desai SS, Hentz VR, Expert Opin Biol Ther 2010 10 9 1395 1404 10.1517/14712598.2010. 510509 20666587
12. The emerging role of Clostridium histolyticum collagenase in the treatment of Dupuytren disease. Thomas A, Bayat A, Ther Clin Risk Manage 2010 6 557 572
13. Injectable collagenase clostridium histolyticum: A new nonsurgical treatment for Dupuytrens disease. Gilpin D, Coleman S, Hall S, Houston A, Karrasch J, Jones N, J Hand Surg Am 2010 35A 2027 2083 e1
14. Injectable collagenase clostridium histolyticum for Dupuytrens contracture. Hurst LC, Badalamente MA, Hentz VR, Hotchkiss RN, Kaplan FT, Meals RA, Smith TM, Rodzvilla J, N Engl J Med 2009 361 10 968 979 10.1056/ NEJMoa0810866 19726771
15. Dupuytrens Disease. McFarlane RM, McGrouther DA, Flint MH, Complications and their management Churchill Livingstone, New York, McFarlane RM, McGrouther DA, Flint MH, 2009 377 382
16. Percutaneous needle fasciotomy in Dupuytrens disease. van Rijssen AL, Werker PM, J Hand Surg Br 2006 31 5 498 501 10.1016/j.jhsb.2006.03.174 16766101 (Pubitemid 44309320)
17. Percutaneous needle aponeurotomy: complications and results. Foucher G, Medina J, Navarro R, J Hand Surg Br 2003 28 5 427 431 10.1016/S0266-7681(03) 00013-5 12954251 (Pubitemid 37168327)
18. A systematic review of outcomes of fasciotomy, aponeurotomy, and collagenase treatments for Dupuytrens contracture. Chen NC, Srinivasan RC, Shauver MJ, Chung KC, Hand 2011 6 3 250 255 10.1007/s11552-011-9326-8
19. Briefing document for collagenase clostridium histolyticum (AA4500) in the treatment of advanced Dupuytrens disease, Arthritis Advisory Committee Meeting. Auxilium Pharmaceuticals, Inc.; September 16, 2009